Skip to main content

Table 5 The impact of the ApoB rs676210 polymorphism on the lipid profile and oxLDL of the control group

From: ApoB gene polymorphism (rs676210) and its pharmacogenetics impact on atorvastatin response among Iraqi population with coronary artery disease

Parameters Genotype (mean+SD)
G/G (n = 66) G/A (n = 28) A/A (n = 6) P value
TC (mg/dl) 140.52±20.01 136.83±26.26 134.02±15.43 0.63
TG (mg/dl) 111.63±17.11 113.47±20.62 115.08±12.49 0.84
HDL (mg/dl) 52.21±9.47 51.49±8.77 49.25±13.35 0.74
LDL (mg/dl) 65.98±19.79 62.65±23.39 61.75±24.49 0.73
VLDL (mg/dl) 22.32±3.42 22.69±4.12 23.01±2.49 0.84
OX-LDL (U/L) 50.20±8.77 43.39±9.66 38.58±12.90 0.42
  1. ANOVA significance test (2-tailed)